KORU Medical Systems to Participate in Canaccord Genuity's 42nd Annual Growth Conference Aug 04, 2022 4:01pm EDT
KORU Medical Systems to Report Second Quarter 2022 Financial Results on August 3, 2022 Jul 20, 2022 4:01pm EDT
KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of EMPAVELI® (pegcetacoplan), Expands European Label for FreedomEdge® May 02, 2022 4:01pm EDT
KORU Medical Systems to Report First Quarter 2022 Financial Results on May 4, 2022 Apr 20, 2022 4:01pm EDT
KORU Medical Systems to Report Fourth Quarter and Full Year 2021 Financial Results on March 2, 2022 Feb 16, 2022 4:01pm EST
KORU Medical Systems Receives FDA 510(k) Clearance for the Use of the FREEDOM60® with Two Additional SCIg Drugs Dec 21, 2021 4:01pm EST
